Assessment of Subcutaneous vs Intravenous Administration of Anti–PD-1 Antibody PF-06801591 in Patients With Advanced Solid Tumors
JAMA Oncology - United States
doi 10.1001/jamaoncol.2019.0836
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2019
Authors
Publisher
American Medical Association (AMA)